Microbiota and kidney disease: the road ahead

Tools

Item Type:	Article
Title:	Microbiota and kidney disease: the road ahead
Creators Name:	Bloom, Patricia P., Garrett, Wendy S., Penniston, Kristina L., Winkler, Mari-Karoliina H., Hazen, Stanley L., Agudelo, Jose, Suryavanshi, Mangesh, Babiker, Ahmed, Dodd, Dylan, Fischbach, Michael A., Huang, Kerwyn Casey, Huttenhower, Curtis, Joe, Bina, Kalantar-Zadeh, Kamyar, Knight, Rob, Miller, Aaron W., Rabb, Hamid, Srivastava, Anvesha, Tang, W. H. Wilson, Turnbaugh, Peter J., Walker, Alan W, Wilck, Nicola, Xu, Jiaojiao, Yang, Tao, Himmelfarb, Jonathan, Redinbo, Matthew R., Wu, Gary D., Woodworth, Michael H., Ackerman, A. Lenore, Winter, Sebastian, Rinschen, Markus M., Hassan, Hatim A., Biruete, Annabel, Anderson, Amanda H. and Pluznick, Jennifer L.
Abstract:	More than 850 million individuals worldwide, accounting for 10–15% of the adult population, are estimated to have chronic kidney disease. Each of these individuals is host to tens of trillions of microorganisms that are collectively referred to as microbiota — a dynamic ecosystem that both influences host health and is itself influenced by changes in the host. Available evidence supports the existence of functional connections between resident microorganisms and kidney health that are altered in the context of specific kidney diseases, including acute kidney injury, chronic kidney disease and renal stone disease. Moreover, promising data from preclinical studies suggest that targeting of gut microbial pathways may provide new therapeutic opportunities for the treatment of kidney disease. This Roadmap describes current understanding of the mechanisms by which microorganisms regulate host organ function, the effects of kidney disease on the gut microbiome, and how these insights may contribute to the development of microbe-targeted therapeutics. We highlight key knowledge gaps that remain to be addressed and strategies for addressing these, outlining both the promise and the potential pitfalls of leveraging our understanding of the gut microbiota to better understand and treat kidney disease.
Source:	Nature Reviews Nephrology
ISSN:	1759-5061
Publisher:	Nature Publishing Group
Date:	28 July 2025
Official Publication:	https://doi.org/10.1038/s41581-025-00988-5
PubMed:	View item in PubMed

Repository Staff Only: item control page